Publication | Closed Access

Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats

Gastrointestinal PharmacologyMedicineGastroenterologyPathologyIrinotecan HydrochlorideAntitumor AgentAnti-cancer AgentActive MetaboliteGut BarrierPharmacology